Related Experiment Video
Updated: Jun 18, 2026
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
In situ hybridization analysis of the induction of interleukin-1beta mRNA by methamphetamine in the rat hypothalamus
T Yamaguchi1, Y Kuraishi, K Yabuuchi
1Department of Pharmacology, Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto 606-01, Japan.
Abstract:
The induction of interleukin-1beta (IL-1beta) mRNA in the rat hypothalamus by systemic treatment with methamphetamine was studied using in situ hybridization. IL-1beta mRNA was expressed throughout the hypothalamus of methamphetamine-treated rats with no apparent signals in that of untreated rats; it was expressed in the paraventricular and periventricular hypothalamic nuclei, medial and lateral preoptic areas, lateral hypothalamic area, suprachiasmatic nucleus, dorsomedial and ventromedial hypothalamic nuclei, premammillary and supramammillary nucleus, median eminence, and arcuate nucleus. The amygdala and paraventricular thalamic nucleus also showed the expression of IL-1beta mRNA. The induction of IL-1beta mRNA in these areas was suppressed by the beta-blocker propranolol (0.1 mg/kg, ip). IL-1beta mRNA-expressing cells were scattered in the hypothalamus and their counterstained profile was dense and small (5-8 mum) findings that suggest glial cells rather than neurons. The present results indicate that IL-1beta mRNA is widely expressed throughout the hypothalamus via beta-adrenoceptors, maybe in glial cells, following the treatment with methamphetamine and that IL-1beta might be involved in various hypothalamic functions induced by methamphetamine.
Insights
Methamphetamine treatment widely induces interleukin-1beta (IL-1beta) mRNA in rat hypothalamus, potentially via beta-adrenoceptors in glial cells. This suggests IL-1beta
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Methamphetamine (METH) is a psychostimulant with complex effects on the central nervous system.
- The hypothalamus regulates numerous physiological functions, and its response to METH is not fully understood.
- Interleukin-1beta (IL-1beta) is a pro-inflammatory cytokine with known roles in neuroinflammation and neuronal function.
Purpose of the Study:
- To investigate the effect of systemic methamphetamine administration on interleukin-1beta mRNA expression in the rat hypothalamus.
- To identify the specific hypothalamic regions affected by methamphetamine-induced IL-1beta mRNA expression.
- To explore the potential involvement of beta-adrenoceptors and cell types in this response.
Main Methods:
- In situ hybridization was used to detect IL-1beta mRNA expression in rat brain tissue.
- Rats were treated systemically with methamphetamine.
- The effect of the beta-blocker propranolol on IL-1beta mRNA induction was examined.
Main Results:
- Methamphetamine treatment induced widespread IL-1beta mRNA expression throughout various hypothalamic nuclei and related areas, including the amygdala and paraventricular thalamic nucleus.
- No significant IL-1beta mRNA signals were observed in untreated control rats.
- The induction of IL-1beta mRNA was significantly suppressed by propranolol, suggesting a role for beta-adrenoceptors.
- The morphology of IL-1beta mRNA-expressing cells suggests they are primarily glial cells rather than neurons.
Conclusions:
- Systemic methamphetamine administration leads to broad induction of IL-1beta mRNA in the rat hypothalamus, potentially mediated by beta-adrenoceptors.
- The findings suggest that IL-1beta, possibly expressed in glial cells, may play a role in mediating various hypothalamic functions affected by methamphetamine.
- Further research is warranted to elucidate the precise mechanisms and functional consequences of IL-1beta induction in the hypothalamus following methamphetamine exposure.
